#Spain #Barcelona #Probiotics #Vitafoods #BioFlag

BioFlag Unveils Groundbreaking Probiotic Solutions at Vitafoods Europe 2025

BioFlag Co., LTD., a prominent Chinese probiotic manufacturer, proudly presented its scientifically validated probiotic solutions at the esteemed Vitafoods Europe 2025 trade show held in Barcelona, Spain on May 20, 2025. The company garnered widespread attention from international media, highlighting its commitment to advancing health through innovative probiotic products.

During the event, BioFlag showcased its cutting-edge probiotic offerings, which include clinically proven strains and ready-to-consume products designed to support gut health, immune regulation, metabolism, weight management, oral health, and emotional well-being. They also unveiled custom probiotic solutions that adhere to stringent European and American standards.

Key Innovations Featured

Among the standout products were several unique strains, each with its own patented benefits:

• - Bifidobacterium animalis subsp. lactis BL-99: Originating from BioFlag's probiotic strain library for mothers and infants, this strain is protected by 12 Chinese patents addressing gut health, immune regulation, and bone health. Its applications include infant nutrition, yogurts, and dietary supplements.

• - Lactobacillus paracasei K56: Isolated from the intestines of healthy Chinese infants, this strain has clinically demonstrated its ability to reduce body fat, visceral fat, and waist circumference, with 9 patents granted in China based on 12 published research studies supporting its efficacy.

• - Bifidobacterium animalis subsp. lactis CP-9: Extracted from the breast milk of healthy Chinese mothers, this strain is patented in China for its effectiveness in combating obesity and treating or preventing jaundice.

As a representative of the Chinese probiotic industry, BioFlag has showcased its comprehensive expertise across the entire industry chain, boasting its own library of over 3,500 strains, more than 30 functional screening platforms, and over 130 patents alongside 100 published scientific papers. The company has received multiple international certifications, including GMP, FSSC22000, and HALAL, and is capable of manufacturing a wide array of dosage forms such as powders, tablets, and capsules.

During the exhibition, BioFlag solidified plans to collaborate with numerous companies and institutions across Europe, North America, and beyond. A spokesperson for the company stated, "With nearly 20 years of experience in functional probiotics, we aim to continue supporting innovation in research and development and intelligent manufacturing, delivering premier health solutions to customers worldwide."

For more information, visit BioFlag's website.

References:
Kadeer G, Fu W, He Y, et al. Effect of different doses of Lacticaseibacillus paracasei K56 on body fat and metabolic parameters in adult individuals with obesity: a pilot study. Nutr Metab. 2023, 20(1):16.